Short Report: Prevalence of Cognitive Impairment in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis

International Journal of MS Care
Giulia DiGiuseppeSarah A Morrow

Abstract

Cognitive impairment is common in multiple sclerosis (MS) and can manifest early in the disease process, sometimes as early as the first demyelinating event. However, the frequency of cognitive impairment in a newly diagnosed MS population has not been evaluated comprehensively in a clinical population. We sought to examine the prevalence of cognitive impairment in relapsing-remitting MS (RRMS) within a year of diagnosis in a clinic where cognitive testing at diagnosis is part of routine practice. A retrospective medical record review of persons with RRMS assessed in a cognitive MS clinic identified 107 patients assessed by the Minimal Assessment of Cognitive Function in Multiple Sclerosis battery within 1 year of a confirmed RRMS diagnosis. The cohort was predominantly female (n = 82 [76.6%]) and white (n = 93 [86.9%]). Only 36 patients (33.6%) were diagnosed as having RRMS based on a second clinical event. Processing speed was the most frequently impaired domain (n = 38 [35.5%]). Only 37 patients (34.6%) were within normal limits on all cognitive domains. Regarding mood symptoms, 25 patients (23.4%) were positive for depressive symptoms; 59 (55.1%), for anxiety. Severe fatigue was correlated with a lower score on the Symbol D...Continue Reading

References

Nov 1, 1991·The British Journal of Clinical Psychology·S A McIntosh-MichaelisA J Spackman
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Jul 22, 1998·Journal of Clinical and Experimental Neuropsychology·R Kail
Oct 16, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·H A DemareeB J Diamond
Nov 30, 2000·Journal of Clinical and Experimental Neuropsychology·C J Archibald, J D Fisk
Jul 19, 2001·Journal of the International Neuropsychological Society : JINS·J V BaldoE Kaplan
Feb 28, 2003·The Clinical Neuropsychologist·Ralph H B BenedictFrederick Munschauer
Jul 15, 2003·Current Opinion in Neurology·Julie A Bobholz, Stephen M Rao
Nov 12, 2005·Annals of Neurology·Chris H PolmanJerry S Wolinsky
May 2, 2006·Journal of the Neurological Sciences·Agnete JønssonMads Ravnborg
Aug 12, 2006·Multiple Sclerosis : Clinical and Laboratory Research·M S A DeloireB Brochet
Sep 20, 2006·Journal of the International Neuropsychological Society : JINS·Ralph H B BenedictBianca Weinstock-Guttman
Jul 31, 2007·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Jeffrey M Rogers, Peter K Panegyres
Jun 25, 2008·Multiple Sclerosis : Clinical and Laboratory Research·B DuqueP Villoslada
Sep 23, 2008·Multiple Sclerosis : Clinical and Laboratory Research·F Patti
Aug 12, 2009·Multiple Sclerosis : Clinical and Laboratory Research·S A MorrowR H B Benedict
Dec 8, 2009·Multiple Sclerosis : Clinical and Laboratory Research·Kimia Honarmand, Anthony Feinstein
Mar 10, 2011·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Jul 13, 2011·Journal of Neurology, Neurosurgery, and Psychiatry·Bonnie I GlanzHoward L Weiner
Nov 17, 2015·The Journal of Neuropsychiatry and Clinical Neurosciences·Sarah A MorrowKoula Pantazopoulos
May 5, 2016·Journal of Clinical and Experimental Neuropsychology·Mervin BlairSarah A Morrow
Oct 1, 2012·Dementia & Neuropsychologia·Carolina Fiorin AnhoqueRenan Barros Domingues

❮ Previous
Next ❯

Citations

Aug 31, 2019·Neurology. Neuroimmunology and Neuroinflammation·Kristen R HollingerBarbara S Slusher
Mar 22, 2019·Biomedicines·Miguel Ángel Macías Islas, Ethel Ciampi
Oct 18, 2020·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Elena Lozano-SotoJavier J González-Rosa
May 26, 2020·Annals of Physical and Rehabilitation Medicine·Elise BaroisPierre Decavel
Feb 13, 2021·Neuropsychiatric Disease and Treatment·Elizabeth S Gromisch, Zaenab Dhari
Jun 15, 2021·Neuropsychological Rehabilitation·Hannah ElwickRoshan das Nair

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Benedetta GorettiMaria Pia Amato
© 2022 Meta ULC. All rights reserved